Peng Zhou1, Che Ping Cheng1, Tiankai Li2, Carlos M Ferrario3, Heng-Jie Cheng4. 1. Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 2. Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USADepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. 3. Department of Surgery, Internal Medicine-Nephrology, and Physiology-Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157-1045, USAInstitute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA hcheng@wakehealth.edu.
Abstract
OBJECTIVE: Recent evidence has shown that, in heart failure (HF), clinically relevant concentrations of angiotensin-(1-7) [Ang-(1-7)] counteracts angiotensin II induced cardiac depression and produces positive inotropic effects in both left ventricle (LV) and myocytes. However, the underlying electrophysiological mechanism is unclear. We investigated the role and mechanism of Ang-(1-7) on LV myocyte L-type calcium current (ICa,L) responses in normal state and in HF. METHOD: We compared the effect of Ang-(1-7) (10(-5) M) on ICa,L responses in isolated LV myocytes obtained from 11 rats with isoproterenol (ISO) induced HF (3 months after 170 mg/kg subcutaneous for 2 days) and from 8 age-matched normal control rats by patch clamp technique. RESULTS: In normal myocytes, compared with baseline, superfusion of Ang-(1-7) caused no significant changes in ICa,L (8.2 ± 0.2 versus 8.0 ± 0.3 pA/pF, p= not significant). In HF myocytes, the baseline ICa,L was significantly reduced (5.3 ± 0.1 versus 8.0 ± 0.3 pA/pF, p < 0.01). Ang-(1-7) produced a 21% increase in ICa,L (6.4±0.1 versus 5.3±0.1 pA/pF, p < 0.01). Pretreatment of HF myocytes with a nitric oxide (NO) synthase inhibitor (L-NAME, 10(-5) M) resulted in a significantly greater increase in ICa,L (28%, 8.4 ± 0.1 versus 6.5 ± 0.1 pA/pF, p < 0.01) during Ang-(1-7) superfusion. In contrast, during incubation with the bradykinin (BK) inhibitor HOE 140 (10(-6) M), Ang-(1-7) induced increase in ICa,L was significantly decreased. The Ang-(1-7) induced increase in ICa,L was abolished by [D-Ala(7)]-Ang-(1-7) (A-779, 10(-5) M). CONCLUSIONS: HF alters the response of ICa,L to Ang-(1-7). In normal myocytes, Ang-(1-7) has no significant effect on ICa,L. However, in HF myocytes, Ang-(1-7) increases ICa,L. These effects are mediated by the Ang-(1-7) Mas receptors and involve activation of NO/BK pathways.
OBJECTIVE: Recent evidence has shown that, in heart failure (HF), clinically relevant concentrations of angiotensin-(1-7) [Ang-(1-7)] counteracts angiotensin II induced cardiac depression and produces positive inotropic effects in both left ventricle (LV) and myocytes. However, the underlying electrophysiological mechanism is unclear. We investigated the role and mechanism of Ang-(1-7) on LV myocyte L-type calcium current (ICa,L) responses in normal state and in HF. METHOD: We compared the effect of Ang-(1-7) (10(-5) M) on ICa,L responses in isolated LV myocytes obtained from 11 rats with isoproterenol (ISO) induced HF (3 months after 170 mg/kg subcutaneous for 2 days) and from 8 age-matched normal control rats by patch clamp technique. RESULTS: In normal myocytes, compared with baseline, superfusion of Ang-(1-7) caused no significant changes in ICa,L (8.2 ± 0.2 versus 8.0 ± 0.3 pA/pF, p= not significant). In HF myocytes, the baseline ICa,L was significantly reduced (5.3 ± 0.1 versus 8.0 ± 0.3 pA/pF, p < 0.01). Ang-(1-7) produced a 21% increase in ICa,L (6.4±0.1 versus 5.3±0.1 pA/pF, p < 0.01). Pretreatment of HF myocytes with a nitric oxide (NO) synthase inhibitor (L-NAME, 10(-5) M) resulted in a significantly greater increase in ICa,L (28%, 8.4 ± 0.1 versus 6.5 ± 0.1 pA/pF, p < 0.01) during Ang-(1-7) superfusion. In contrast, during incubation with the bradykinin (BK) inhibitor HOE 140 (10(-6) M), Ang-(1-7) induced increase in ICa,L was significantly decreased. The Ang-(1-7) induced increase in ICa,L was abolished by [D-Ala(7)]-Ang-(1-7) (A-779, 10(-5) M). CONCLUSIONS: HF alters the response of ICa,L to Ang-(1-7). In normal myocytes, Ang-(1-7) has no significant effect on ICa,L. However, in HF myocytes, Ang-(1-7) increases ICa,L. These effects are mediated by the Ang-(1-7) Mas receptors and involve activation of NO/BK pathways.
Authors: Annemarieke E Loot; Anton J M Roks; Robert H Henning; René A Tio; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst Journal: Circulation Date: 2002-04-02 Impact factor: 29.690
Authors: Luciana Gonçalves Maia; Marcela Caldeira Ramos; Liliam Fernandes; Maria Helena Catelli de Carvalho; Maria José Campagnole-Santos; Robson Augusto Souza dos Santos Journal: J Cardiovasc Pharmacol Date: 2004-05 Impact factor: 3.105
Authors: Carlos M Ferrario; Ronald D Smith; Bridget Brosnihan; Mark C Chappell; Vito M Campese; Ole Vesterqvist; Wei-chi Liao; Michael C Ruddy; Clarence E Grim Journal: Am J Hypertens Date: 2002-06 Impact factor: 2.689
Authors: Mariana B L Carvalho; Fernanda V Duarte; Raphael Faria-Silva; Beatrix Fauler; Leonor T da Mata Machado; Renata D de Paula; Maria J Campagnole-Santos; Robson A S Santos Journal: Hypertension Date: 2007-07-30 Impact factor: 10.190